首页> 外文期刊>The Open Medicinal Chemistry Journal >Molecular Docking, Pharmacophore, and 3D-QSAR Approach: Can Adenine Derivatives Exhibit Significant Inhibitor Towards Ebola Virus?
【24h】

Molecular Docking, Pharmacophore, and 3D-QSAR Approach: Can Adenine Derivatives Exhibit Significant Inhibitor Towards Ebola Virus?

机译:分子对接,药理学和3D-QSAR方法:腺嘌呤衍生物能否对埃博拉病毒表现出重要的抑制作用?

获取原文
           

摘要

Introduction:Ebola Virus Disease (EVD) is caused by Ebola virus, which is often accompanied by fatal hemorrhagic fever upon infection in humans. This virus has caused the majority of deaths in human. There are no proper vaccinations and medications available for EVD. It is pivoting the attraction of scientist to develop the potent vaccination or novel lead to inhibit Ebola virus.Methods & Materials:In the present study, we developed 3D-QSAR and the pharmacophoric model from the previous reported potent compounds for the Ebola virus.Results & Discussion:Results & Discussion: The pharmacophoric model AAAP.116 was generated with better survival value and selectivity. Moreover, the 3D-QSAR model also showed the best r2 value 0.99 using PLS factor. Thereby, we found the higher F value, which demonstrated the statistical significance of both the models. Furthermore, homological modeling and molecular docking study were performed to analyze the affinity of the potent lead. This showed the best binding energy and bond formation with targeted protein.Conclusion:Finally, all the results of this study concluded that 3D-QSAR and Pharmacophore models may be helpful to search potent lead for EVD treatment in future.
机译:简介:埃博拉病毒病(EVD)是由埃博拉病毒引起的,人类感染后常伴有致命性出血热。该病毒已导致大多数人死亡。没有适当的疫苗和药物可用于EVD。方法和材料:在本研究中,我们从先前报道的有效的埃博拉病毒有效化合物中开发了3D-QSAR和药效学模型。与讨论:结果与讨论:药效学模型AAAP.116具有更好的生存价值和选择性。此外,使用PLS因子,3D-QSAR模型也显示出最佳的r2值0.99。因此,我们发现较高的F值,这表明了两个模型的统计意义。此外,进行了同源建模和分子对接研究,以分析有效铅的亲和力。结论:最后,所有研究结果得出结论,3D-QSAR和Pharmacophore模型可能有助于寻找潜在的EVD治疗药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号